Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Prometheus Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 18.5K | 0 | −18.5K (−100.0%) |
| Value | $1.98M | $0 | −$1.98M (−100.0%) |
New holders (0)
Institutions that held Prometheus Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (2)
Institutions that held Prometheus Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| UBS Asset Management Americas Inc | 18,448 | $1.98M |
| FinTrust Capital Advisors, LLC | 13 | $1.43K |